These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 32484272)

  • 1. Discovery of phthalimide derivatives as novel inhibitors of a soluble epoxide hydrolase.
    Mahlooji I; Shokri M; Manoochehri R; Mahboubi-Rabbani M; Rezaee E; Tabatabai SA
    Arch Pharm (Weinheim); 2020 Aug; 353(8):e2000052. PubMed ID: 32484272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel amide derivatives of 3-phenylglutaric acid as potent soluble epoxide hydrolase inhibitors.
    Rezaee E; Amrolah SM; Nazari M; Tabatabai SA
    Mol Divers; 2021 Feb; 25(1):45-53. PubMed ID: 31873869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Investigation of the binding mode of 1, 3, 4-oxadiazole derivatives as amide-based inhibitors for soluble epoxide hydrolase (sEH) by molecular docking and MM-GBSA.
    Karami L; Saboury AA; Rezaee E; Tabatabai SA
    Eur Biophys J; 2017 Jul; 46(5):445-459. PubMed ID: 27928588
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quinazoline-4(3H)-one derivatives as novel and potent inhibitors of soluble epoxide hydrolase: Design, synthesis and biological evaluation.
    Hejazi L; Rezaee E; Tabatabai SA
    Bioorg Chem; 2020 Jun; 99():103736. PubMed ID: 32229350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of novel drug candidates for inhibition of soluble epoxide hydrolase of arachidonic acid cascade pathway implicated in atherosclerosis.
    Gurung AB; Mayengbam B; Bhattacharjee A
    Comput Biol Chem; 2018 Jun; 74():1-11. PubMed ID: 29522918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, Docking Study and Biological Evaluation of Amide-Based Soluble Epoxide Hydrolase Inhibitors with Novel Secondary Pharmacophore of Pyrimidin-2-ol.
    Hejazi L; Ebadi A; Fakhar Z; Nazari M; Rezaee E; Abbas Tabatabai S
    Chem Biodivers; 2022 Nov; 19(11):e202200231. PubMed ID: 36152343
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparation and evaluation of soluble epoxide hydrolase inhibitors with improved physical properties and potencies for treating diabetic neuropathic pain.
    Lee KSS; Ng JC; Yang J; Hwang SH; Morisseau C; Wagner K; Hammock BD
    Bioorg Med Chem; 2020 Nov; 28(22):115735. PubMed ID: 33007552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of bioavailable derivatives of 12-(3-adamantan-1-yl-ureido)dodecanoic acid, a potent inhibitor of the soluble epoxide hydrolase.
    Kim IH; Nishi K; Tsai HJ; Bradford T; Koda Y; Watanabe T; Morisseau C; Blanchfield J; Toth I; Hammock BD
    Bioorg Med Chem; 2007 Jan; 15(1):312-23. PubMed ID: 17046265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Isolation of soluble epoxide hydrolase inhibitor of capsaicin analogs from Capsicum chinense Jacq. cv. Habanero.
    Kim JH; Jo YD; Jin CH
    Int J Biol Macromol; 2019 Aug; 135():1202-1207. PubMed ID: 31175899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-activity relationships of substituted oxyoxalamides as inhibitors of the human soluble epoxide hydrolase.
    Kim IH; Lee IH; Nishiwaki H; Hammock BD; Nishi K
    Bioorg Med Chem; 2014 Feb; 22(3):1163-75. PubMed ID: 24433964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Further exploration of the structure-activity relationship of dual soluble epoxide hydrolase/fatty acid amide hydrolase inhibitors.
    Wilt S; Kodani S; Valencia L; Hudson PK; Sanchez S; Quintana T; Morisseau C; Hammock BD; Kandasamy R; Pecic S
    Bioorg Med Chem; 2021 Dec; 51():116507. PubMed ID: 34794001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Discovery of benzamide derivatives containing urea moiety as soluble epoxide hydrolase inhibitors.
    Tian Y; Li S; Dong K; Su X; Fu S; Lv X; Duan M; Yang T; Han Y; Hu G; Liu J; Sun Y; Yue H; Sun Y; Zhang H; Du Z; Miao Z; Tong M; Liu Y; Qin M; Gong P; Hou Y; Gao Z; Zhao Y
    Bioorg Chem; 2022 Oct; 127():105898. PubMed ID: 35792317
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble epoxide hydrolase inhibitors with carboranes as non-natural 3-D pharmacophores.
    Scholz MS; Wingen LM; Brunst S; Wittmann SK; Cardoso ILA; Weizel L; Proschak E
    Eur J Med Chem; 2020 Jan; 185():111766. PubMed ID: 31677445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring the size of the lipophilic unit of the soluble epoxide hydrolase inhibitors.
    Codony S; Valverde E; Leiva R; Brea J; Isabel Loza M; Morisseau C; Hammock BD; Vázquez S
    Bioorg Med Chem; 2019 Oct; 27(20):115078. PubMed ID: 31488357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble epoxide hydrolase inhibitory activity of anthraquinone components from Aloe.
    Sun YN; Kim JH; Li W; Jo AR; Yan XT; Yang SY; Kim YH
    Bioorg Med Chem; 2015 Oct; 23(20):6659-65. PubMed ID: 26372074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery and Optimization of Piperazine Urea Derivatives as Soluble Epoxide Hydrolase (sEH) Inhibitors.
    Çapan İ; Jordan PM; Olğaç A; Çalışkan B; Kretzer C; Werz O; Banoglu E
    ChemMedChem; 2022 Jun; 17(12):e202200137. PubMed ID: 35466565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ligand-based optimization to identify novel 2-aminobenzo[d]thiazole derivatives as potent sEH inhibitors with anti-inflammatory effects.
    Han Y; Huang D; Xu S; Li L; Tian Y; Li S; Chen C; Li Y; Sun Y; Hou Y; Sun Y; Qin M; Gong P; Gao Z; Zhao Y
    Eur J Med Chem; 2021 Feb; 212():113028. PubMed ID: 33248848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro and in silico investigation of anthocyanin derivatives as soluble epoxide hydrolase inhibitors.
    Kim JH; Cho IS; Ryu J; Lee JS; Kang JS; Kang SY; Kim YH
    Int J Biol Macromol; 2018 Jun; 112():961-967. PubMed ID: 29447963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacophoric modeling and atom-based 3D-QSAR of novel 1-aryl-3-(1-acylpiperidin-4-yl) urea as human soluble epoxide hydrolase inhibitors (sEHIs).
    Das N; Dhanawat M; Kulshrestha A; Shrivastava SK
    Med Chem; 2011 Nov; 7(6):581-92. PubMed ID: 22313298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the Therapeutic Potential of Sulfonyl Urea Derivatives as Soluble Epoxide Hydrolase (sEH) Inhibitors.
    Kundu B; Dvorácskó S; Basu A; Pommerolle L; Kim KA; Wood CM; Gibbs E; Behee M; Tarasova NI; Cinar R; Iyer MR
    Molecules; 2024 Jun; 29(13):. PubMed ID: 38998987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.